High Dose Ribavirin and Peginterferon for Chronic Hepatitis C Non-responders or Relapsers

被引：0
|
作者：
Gara, Naveen [1 ]
Abdalla, Adil A. [1 ]
Rivera, Elenita M. [1 ]
Zhao, Xiongce [1 ]
Fryzek, Nancy [1 ]
Noureddin, Mazen [1 ]
Sarkar, Souvik [1 ]
Heller, Theo [1 ]
Rotman, Yaron [1 ]
Doo, Edward [1 ]
Liang, T. Jake [1 ]
Hoofnagle, Jay H. [1 ]
Ghany, Marc G. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1836
引用
收藏
页码：1049A / 1049A
页数：1
相关论文
共 50 条
  • [31] Management of treatment non-responders in chronic hepatitis C
    Poynard, T.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S38 - S38
  • [32] A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon.
    Kumar, KS
    Malik, AH
    Malet, PF
    Ostapowicz, G
    Wood, M
    Jones, A
    Lee, WM
    GASTROENTEROLOGY, 2000, 118 (04) : A1488 - A1488
  • [33] High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C
    Di Marco, V
    Vaccaro, A
    Ferraro, D
    Alaimo, G
    Rodolico, V
    Parisi, P
    Peralta, S
    Di Stefano, R
    Almasio, PL
    Craxì, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (07) : 953 - 958
  • [34] Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial
    Ishida, H
    Inoue, Y
    Wong, JB
    Okita, K
    HEPATOLOGY RESEARCH, 2004, 28 (03) : 125 - 136
  • [35] High response rates with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in Japanese non-responders or relapsers to conventional interferon
    Izumi, N.
    Iino, S.
    Okuno, T.
    Omata, M.
    Kiyosawa, K.
    Kumada, H.
    Hayashi, N.
    Yamada, G.
    Sakai, T.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S216 - S216
  • [36] Peginterferon and ribavirin for chronic hepatitis C
    Hoofnagle, Jay H.
    Seeff, Leonard B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23): : 2444 - 2451
  • [37] High dose interferon alfa-2b (IFN) with or without ribavirin (RIB) for chronic hepatitis C in non-responders to standard therapy.
    Wood, MM
    Malet, PF
    Jones, A
    Prebis, M
    Harford, W
    Lee, WM
    HEPATOLOGY, 1998, 28 (04) : 283A - 283A
  • [38] High-dose interferon alfacon-1 is a treatment option for non-responders and relapsers to combined therapy with interferon and ribavirin.
    Sjogren, MH
    Wu, G
    Herrine, SK
    Raufman, JP
    Bacon, BR
    Epstein, M
    Medoff, J
    Chen, S
    Waters, B
    Krawitt, E
    Sjogren, RW
    Herrera, J
    HEPATOLOGY, 2000, 32 (04) : 352A - 352A
  • [39] Interim results of the NYNEST interferon-ribavirin retreatment trial in chronic hepatitis C non-responders
    Krawitt, EL
    Albertini, R
    John, A
    Gordon, S
    Cimis, R
    Maheshwari, Y
    Kaplan, M
    Moskowitz, S
    Schapira, L
    Kilby, A
    Antignano, L
    Malamood, H
    Notis, W
    Brand, M
    Wu, G
    Yarze, J
    Brass, C
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [40] RETREATMENT OF CHRONIC HEPATITIS C-GENOTYPE 1-INFECTED RELAPSERS TO PEGINTERFERON/RIBAVIRIN WITH CONSENSUS INTERFERON/RIBAVIRIN OR WITH EXTENDED DURATION THERAPY PEGINTERFERON/RIBAVIRIN
    Pearlman, Brian
    Ehleben, Carole
    HEPATOLOGY, 2009, 50 (04) : 686A - 686A
12345